1 Blood and Hemostasis Foundations
Learn how blood components, blood-cell production, hemostasis, and core laboratory tests help explain oxygen delivery, immune defense, bleeding, and clotting.
Blood components and their roles
Blood disorders can affect oxygen delivery, infection defense, or the control of bleeding and clotting. Blood’s components have distinct but connected roles, and changes in them can help explain clinical findings.
Blood components and their roles
The formed elements of blood are red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). is the liquid portion that carries these cells and dissolved substances.
Red blood cells: Carry oxygen using hemoglobin and transport some carbon dioxide. Low hemoglobin or red-cell mass can reduce tissue oxygen delivery; an abnormal cell size or shape may suggest a particular disorder.
White blood cells: Support immune defense and include neutrophils, lymphocytes, monocytes, eosinophils, and basophils. The total count and differential help assess infection, inflammation, and hematologic disease.
Platelets: Cell fragments that adhere and aggregate at vessel injuries and also support coagulation. A low count or impaired function can increase bleeding risk; a high count does not necessarily mean platelet function is normal.
: Transports cells and dissolved substances and contains proteins, including coagulation factors. Changes in proteins or clotting factors can affect fluid balance, immunity, and .
Blood-cell production
is the ongoing production of blood cells, primarily in the bone marrow. Blood-cell lineages arise from hematopoietic stem cells, which can renew themselves and differentiate into committed progenitors. These progenitors mature into red cells, white cells, or platelet-producing megakaryocytes.
Production responds to the body’s needs. For example, low tissue oxygen stimulates the kidneys to release erythropoietin, which promotes red-cell production. Mature blood cells have limited lifespans and must be continually replaced.
A is a young red cell newly released from the marrow. An increased response may indicate that the marrow is compensating for blood loss or red-cell destruction. In anemia, a low or insufficient response may indicate reduced production; interpretation depends on the degree of anemia and the clinical context.
How works
is the coordinated process that limits blood loss after vessel injury. It depends on the vessel wall, platelets, and coagulation factors, while regulatory mechanisms prevent clotting from spreading unnecessarily.
Vascular response: The injured vessel constricts, temporarily reducing blood flow at the site.
Primary : Platelets adhere to exposed vessel structures, with von Willebrand factor (VWF) helping them attach. Activated platelets release signals that recruit and activate additional platelets, which aggregate to form a temporary platelet plug.
Coagulation: Coagulation reactions generate thrombin. Thrombin converts soluble fibrinogen into fibrin, which reinforces the platelet plug and creates a more stable clot.
Regulation and fibrinolysis: Natural anticoagulant systems limit clot formation. As healing progresses, plasmin breaks down fibrin and helps remove the clot.
This sequence is a useful learning model; in the body, coagulation reactions are interconnected and occur on cell surfaces.
Bleeding patterns as clues
Bleeding patterns can offer clues about the part of that may be affected, but they are not diagnoses. Defects in platelets or VWF often cause mucosal or skin bleeding, such as nosebleeds, gum bleeding, petechiae, or easy bruising. Coagulation-factor problems may cause prolonged bleeding or bleeding into joints and muscles.
and differential
A measures the number and characteristics of circulating blood cells. It commonly reports hemoglobin, hematocrit, red blood cell count, white blood cell count, and platelet count. A differential reports the types and numbers or proportions of white blood cells.
Red blood cell indices describe cell size and hemoglobin content: MCV is mean corpuscular volume, MCH is mean corpuscular hemoglobin, MCHC is mean corpuscular hemoglobin concentration, and RDW describes variation in red blood cell size. findings identify patterns to investigate, but do not by themselves establish the cause.
count and blood smear
A count helps assess the bone marrow’s response to anemia. A peripheral blood smear allows visual assessment of cell size, shape, maturity, and appearance. The smear may reveal findings not captured by cell counts alone and can help guide further testing.
Coagulation screening tests
screens the tissue-factor, often called extrinsic, and common coagulation pathways. It is commonly reported with the , which standardizes PT results and is used to monitor warfarin therapy.
screens the intrinsic and common pathways and is commonly used to assess unfractionated heparin therapy. Prolonged PT or aPTT results can have multiple causes, including factor deficiencies, inhibitors, medication effects, or other illness. Interpret results with the clinical picture and the reporting laboratory’s reference ranges.
Additional tests for specific questions
Additional tests are selected to address a clinical question and interpret findings that initial tests do not explain.
Fibrinogen: Measures a key clot-forming protein. Low levels may occur with consumption or impaired production.
: Reflects breakdown of cross-linked fibrin. An elevated result is nonspecific, must be interpreted in context, and does not independently diagnose a clotting disorder.
Platelet-function or VWF testing: May be considered when the platelet count and routine coagulation tests do not explain a bleeding history.
Factor assays and mixing studies: Can help investigate abnormal PT or aPTT results. A compares patient with normal ; correction may support a factor deficiency, while failure to correct can suggest an inhibitor. Specialized interpretation is required.
Bone marrow aspiration or biopsy: May be used when blood counts, smear findings, or the clinical picture suggest a marrow-production problem.
Applying tests to a bleeding history
For a patient with frequent nosebleeds, a , platelet count, smear, PT/INR, and aPTT may be ordered. The and smear assess cell counts and appearance; the platelet count helps identify thrombocytopenia; and PT/INR and aPTT screen different parts of the coagulation system. If these initial tests do not explain the bleeding, the care team may consider further platelet, VWF, or factor testing.
The nurse should promptly report active or worsening bleeding and relevant symptoms, verify medication and bleeding history, and ensure specimens are collected and handled according to laboratory requirements.
Interpreting findings in context
Interpret laboratory values alongside the patient’s symptoms, history, medications, trends, and the reporting laboratory’s reference ranges. Blood tests help identify patterns and guide further investigation; individual findings should not be treated as diagnoses without the clinical context.
Together, blood components and support oxygen delivery, immune defense, and clotting. continually replaces blood cells, while coordinates vessel responses, platelet-plug formation, fibrin generation, and clot removal.